• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Imexon

CAS No. 59643-91-3

Imexon ( Amplimexon;BM 06002 )

产品货号. M15211 CAS No. 59643-91-3

A 2-cyanoaziridine derivative with antitumor activity in some types of cancer.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥11097 有现货
50MG ¥22518 有现货
100MG ¥29970 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Imexon
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    A 2-cyanoaziridine derivative with antitumor activity in some types of cancer.
  • 产品描述
    A 2-cyanoaziridine derivative with antitumor activity in some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma; induces mitochondrial oxidation and induces apoptosis via a pathway involving cleaved caspase-3, caspase-9, and/or caspase-8; an apoptosis inducer agent.Blood Cancer Phase 2 Clinical
  • 同义词
    Amplimexon;BM 06002
  • 通路
    Apoptosis
  • 靶点
    Apoptosis
  • 受体
    Apoptosis
  • 研究领域
    Cancer
  • 适应症
    Blood cancer

化学信息

  • CAS Number
    59643-91-3
  • 分子量
    111.10
  • 分子式
    C4H5N3O
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    O=C1N2CC2C(N)=N1
  • 化学全称
    4-Amino-1,3-diazabicyclo[3.1.0]hex-3-en-2-one

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Ziegler AE, et al. Exp Pathol (Jena). 1977;14(6):321-7.
2. Hersh EM, et al. J Natl Cancer Inst. 1992 Aug 19;84(16):1238-44.
3. Baker AF, et al. Clin Cancer Res. 2007 Jun 1;13(11):3388-94.
产品手册
关联产品
  • Oxypeucedanin

    Oxypeucedanin has novel anticancer effect, mediated via induction of G2-M cell cycle arrest and apoptosis in human prostate carcinoma DU145 cells.

  • K145 hydrochloride

    K145 hydrochloride is a selective sphk2 inhibitor with substrate competitiveness and oral activity, with IC50 of 4.3 μM and Ki of 6.4 μM. K145 hydrochloride can induce apoptosis and has strong antitumor activity.

  • DCH36_06

    DCH36_06? as a bona fide is a potent p300/CBP inhibitor